TABLE OF CONTENTS
Volume 34, Issue 12 (December (2) 2004)
Review |
Conditioning Regimens |
Allografting |
Autografting |
Post-Transplant Events |
Graft Versus Tumor Effects |
In Vitro Studies |
Correspondence
Editorial
Who will regulate the regulators? FREE
J M Goldman
Bone Marrow Transplant 34: 1013-1014; doi:10.1038/sj.bmt.1704775
Review
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation FREE
A Woywodt, M Haubitz, S Buchholz and B Hertenstein
Bone Marrow Transplant 34: 1015-1023; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704733
Conditioning Regimens
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate FREE
M A Gertz, M Q Lacy, A Dispenzieri, S M Ansell, M A Elliott, D A Gastineau, D J Inwards, I N M Micallef, L F Porrata, A Tefferi and M R Litzow
Bone Marrow Transplant 34: 1025-1031; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704691
First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party FREE
G Rosti, U De Giorgi, H Wandt, B Lioure, S Leyvraz, K Kolbe, G Papiani, M Ballardini, A Kulekci and T Demirer on behalf of the EBMT Solid Tumours Working Party
Bone Marrow Transplant 34: 1033-1037; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704704
Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies FREE
E P Alessandrino, P Bernasconi, A A Colombo, D Caldera, L Malcovati, D Troletti, L Vanelli, M Varettoni, F Montanari and M Lazzarino
Bone Marrow Transplant 34: 1039-1045; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704717
Allografting
Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia FREE
M Koldehoff, D W Beelen, R Trenschel, N K Steckel, R Peceny, M Ditschkowski, H Ottinger and A H Elmaagacli
Bone Marrow Transplant 34: 1047-1050; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704686
Autografting
Engraftment syndrome after autologous peripheral blood progenitor cell transplantation in pediatric patients: a prospective evaluation of risk factors and outcome FREE
M González-Vicent, M Ramírez, J Sevilla, A Pérez, S Fernández, L Madero and M A Díaz
Bone Marrow Transplant 34: 1051-1055; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704698
Post-Transplant Events
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome FREE
R Zeiser, B Deschler, H Bertz, J Finke and M Engelhardt
Bone Marrow Transplant 34: 1057-1065; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704713
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients FREE
P Ljungman, J Aschan, B Gustafsson, I Lewensohn-Fuchs, J Winiarski and O Ringdén
Bone Marrow Transplant 34: 1067-1069; advance online publication, October 18, 2004; doi:10.1038/sj.bmt.1704678
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection FREE
R K Avery, B J Bolwell, B Yen-Lieberman, N Lurain, W J Waldman, D L Longworth, A J Taege, S B Mossad, D Kohn, J R Long, J Curtis, M Kalaycio, B Pohlman and J W Williams
Bone Marrow Transplant 34: 1071-1075; advance online publication, October 18, 2004; doi:10.1038/sj.bmt.1704694
A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children FREE
M González-Vicent, L Madero, J Sevilla, M Ramirez and M A Díaz
Bone Marrow Transplant 34: 1077-1081; advance online publication, November 1, 2004; doi:10.1038/sj.bmt.1704699
Graft Versus Tumor Effects
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease FREE
M Weisser, M Schleuning, G Ledderose, B Rolf, S Schnittger, C Schoch, R Schwerdtfeger and H J Kolb
Bone Marrow Transplant 34: 1083-1088; advance online publication, October 18, 2004; doi:10.1038/sj.bmt.1704664
In Vitro Studies
Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma FREE
D Decaudin, J-M Vantelon, J-H Bourhis, F Farace, M-L Bonnet, M Guillier, N Greissenger, M-C Marracho, S Assari, A-L Bennaceur, F Némati, J Michon, A G Turhan and C Boccaccio
Bone Marrow Transplant 34: 1089-1093; advance online publication, October 18, 2004; doi:10.1038/sj.bmt.1704675
Correspondence
G-CSF-mobilised granulocyte transfusion to an ALL patient complicated by cytomegalovirus transmission FREE
U Meyer-Koenig, F T Hufert, U Duffner, D Neumann-Haefelin and M Henschen
Bone Marrow Transplant 34: 1095-1096; advance online publication, October 25, 2004; doi:10.1038/sj.bmt.1704644
High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus FREE
Y Oyama, E R Parker, J Brieva, J Guitart, L Statkute, L Verda and R K Burt
Bone Marrow Transplant 34: 1097-1098; advance online publication, October 18, 2004; doi:10.1038/sj.bmt.1704679
Successful pregnancies after bone marrow transplantation for Fanconi anemia FREE
J H Dalle, C Huot, M Duval, P Rousseau, D Francoeur, J Champagne, M F Vachon and M A Champagne
Bone Marrow Transplant 34: 1099-1100; advance online publication, October 18, 2004; doi:10.1038/sj.bmt.1704680
